Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 76,204 | 63,511 | 85,264 | 92,917 | 64,153 |
| Cost of Goods | 31,487 | 26,400 | 27,492 | 31,369 | 26,085 |
| Gross Profit | 44,717 | 37,111 | 57,772 | 61,548 | 38,068 |
| Operating Expenses | 36,715 | 21,831 | 24,063 | 27,253 | 28,679 |
| Operating Income | 8,489 | 15,680 | 34,201 | 34,664 | 9,474 |
| Interest Expense | 428 | 444 | 472 | 534 | 630 |
| Other Income | -205 | 59 | -677 | 118 | -1,097 |
| Pre-tax Income | 7,856 | 15,295 | 33,052 | 34,248 | 7,747 |
| Income Tax | 1,199 | 3,626 | 6,750 | 7,469 | 1,254 |
| Net Income Continuous | 6,657 | 11,669 | 26,302 | 26,779 | 6,493 |
| Net Income | $6,657 | $11,669 | $26,302 | $26,779 | $6,493 |
| EPS Basic Total Ops | 0.15 | 0.27 | 0.61 | 0.62 | 0.15 |
| EPS Basic Continuous Ops | 0.15 | 0.27 | 0.61 | 0.62 | 0.15 |
| EPS Diluted Total Ops | 0.15 | 0.26 | 0.60 | 0.61 | 0.14 |
| EPS Diluted Continuous Ops | 0.15 | 0.26 | 0.60 | 0.61 | 0.15 |
| EPS Diluted Before Non-Recurring Items | 0.23 | 0.22 | 0.56 | N/A | N/A |
| EBITDA(a) | $12,593 | $19,427 | $37,907 | $38,393 | $13,675 |